Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapy for myositis.
Oddis CV. Oddis CV. Curr Opin Rheumatol. 1991 Dec;3(6):919-24. doi: 10.1097/00002281-199112000-00004. Curr Opin Rheumatol. 1991. PMID: 1772745 Review.
Anti-U3 RNP autoantibodies in systemic sclerosis.
Aggarwal R, Lucas M, Fertig N, Oddis CV, Medsger TA Jr. Aggarwal R, et al. Among authors: oddis cv. Arthritis Rheum. 2009 Apr;60(4):1112-8. doi: 10.1002/art.24409. Arthritis Rheum. 2009. PMID: 19333934 Free article.
Therapeutic approaches in myositis.
Aggarwal R, Oddis CV. Aggarwal R, et al. Among authors: oddis cv. Curr Rheumatol Rep. 2011 Jun;13(3):182-91. doi: 10.1007/s11926-011-0172-z. Curr Rheumatol Rep. 2011. PMID: 21365210 Review.
Paraneoplastic myalgias and myositis.
Aggarwal R, Oddis CV. Aggarwal R, et al. Among authors: oddis cv. Rheum Dis Clin North Am. 2011 Nov;37(4):607-21. doi: 10.1016/j.rdc.2011.09.007. Epub 2011 Oct 24. Rheum Dis Clin North Am. 2011. PMID: 22075200 Review.
Therapeutic advances in myositis.
Aggarwal R, Oddis CV. Aggarwal R, et al. Among authors: oddis cv. Curr Opin Rheumatol. 2012 Nov;24(6):635-41. doi: 10.1097/BOR.0b013e328358ac72. Curr Opin Rheumatol. 2012. PMID: 22955021 Review.
Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases.
Saketkoo LA, Mittoo S, Frankel S, LeSage D, Sarver C, Phillips K, Strand V, Matteson EL; OMERACT Connective Tissue Disease–Interstitial Lung Diseases Working Group; OMERACT Connective Tissue Disease-Interstitial Lung Diseases Working Group. Saketkoo LA, et al. J Rheumatol. 2014 Apr;41(4):792-8. doi: 10.3899/jrheum.131251. Epub 2014 Feb 1. J Rheumatol. 2014. PMID: 24488412 Free PMC article. Review.
Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.
Aggarwal R, Bandos A, Reed AM, Ascherman DP, Barohn RJ, Feldman BM, Miller FW, Rider LG, Harris-Love MO, Levesque MC; RIM Study Group; Oddis CV. Aggarwal R, et al. Among authors: oddis cv. Arthritis Rheumatol. 2014 Mar;66(3):740-9. doi: 10.1002/art.38270. Arthritis Rheumatol. 2014. PMID: 24574235 Free PMC article. Clinical Trial.
206 results